Mn porphyrins as a novel treatment targeting sickle cell NOXs to reverse and prevent acute vaso-occlusion in vivo

M Thamilarasan, R Estupinan… - Blood …, 2020 - ashpublications.org
In sickle cell disease (SCD), adhesion of sickle red blood cells (SSRBCs) and activated
leukocytes in inflamed venules affects blood rheology, causing vaso-occlusive …
被引用次数：18 相关文章
[HTML] nih.gov

[HTML][HTML] Mn porphyrins as a novel treatment targeting sickle cell NOXs to reverse and prevent acute vaso-occlusion in vivo

M Thamilarasan, R Estupinan, I Batinic-Haberle… - Blood …, 2020 - ncbi.nlm.nih.gov
In sickle cell disease (SCD), adhesion of sickle red blood cells (SSRBCs) and activated
leukocytes in inflamed venules affects blood rheology, causing vaso-occlusive …

Mn porphyrins as a novel treatment targeting sickle cell NOXs to reverse and prevent acute vaso-occlusion in vivo

M Thamilarasan, R Estupinan, I Batinic-Haberle… - Blood Advances, 2020 - Elsevier
In sickle cell disease (SCD), adhesion of sickle red blood cells (SSRBCs) and activated
leukocytes in inflamed venules affects blood rheology, causing vaso-occlusive …

Mn porphyrins as a novel treatment targeting sickle cell NOXs to reverse and prevent acute vaso-occlusion in vivo

M Thamilarasan, R Estupinan, I Batinic-Haberle… - 2020 - hero.epa.gov
In sickle cell disease (SCD), adhesion of sickle red blood cells (SSRBCs) and activated
leukocytes in inflamed venules affects blood rheology, causing vaso-occlusive …

Mn porphyrins as a novel treatment targeting sickle cell NOXs to reverse and prevent acute vaso-occlusion in vivo

M Thamilarasan, R Estupinan… - Blood …, 2020 - pubmed.ncbi.nlm.nih.gov
In sickle cell disease (SCD), adhesion of sickle red blood cells (SSRBCs) and activated
leukocytes in inflamed venules affects blood rheology, causing vaso-occlusive …
[PDF] researchgate.net

[PDF][PDF] Mn porphyrins as a novel treatment targeting sickle cell NOXs to reverse and prevent acute vaso-occlusion in vivo

M Thamilarasan, R Estupinan, I Batinic-Haberle… - 2020 - researchgate.net
In sickle cell disease (SCD), adhesion of the red blood cell (RBC) carrying hemoglobin S
(HbS) to endothelial cells (ECs) has been postulated to play a key role in vessel obstruction …
[HTML] duke.edu

[HTML][HTML] Mn porphyrins as a novel treatment targeting sickle cell NOXs to reverse and prevent acute vaso-occlusion in vivo.

M Thamilarasan, R Estupinan, I Batinic-Haberle… - 2020 - dukespace.lib.duke.edu
In sickle cell disease (SCD), adhesion of sickle red blood cells (SSRBCs) and activated
leukocytes in inflamed venules affects blood rheology, causing vaso-occlusive …

Mn porphyrins as a novel treatment targeting sickle cell NOXs to reverse and prevent acute vaso-occlusion in vivo.

M Thamilarasan, R Estupinan, I Batinic-Haberle… - Blood …, 2020 - europepmc.org
In sickle cell disease (SCD), adhesion of sickle red blood cells (SSRBCs) and activated
leukocytes in inflamed venules affects blood rheology, causing vaso-occlusive …
[PDF] duke.edu

[PDF][PDF] Mn porphyrins as a novel treatment targeting sickle cell NOXs to reverse and prevent acute vaso-occlusion in vivo

M Thamilarasan, R Estupinan, I Batinic-Haberle… - 2020 - dukespace.lib.duke.edu
In sickle cell disease (SCD), adhesion of the red blood cell (RBC) carrying hemoglobin S
(HbS) to endothelial cells (ECs) has been postulated to play a key role in vessel obstruction …